Surmodics's average Accounts Payable for the
three
months ended in Jun. 2025 was $4.7 Mil. Surmodics's Cost of Goods Sold for the
three
months ended in Jun. 2025 was $16.1 Mil.
Hence, Surmodics's Days Payable for the
three
months ended in Jun. 2025 was 26.32.
The historical rank and industry rank for Surmodics's Days Payable or its related term are showing as below:
SRDX'
s Days Payable Range Over the Past 10 Years
Min: 9.42 Med: 14.05 Max: 19.42
Current: 19.42
During the past 13 years, Surmodics's highest Days Payable was 19.42. The lowest was 9.42. And the median was 14.05.
SRDX's Days Payable is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 67.87
vs SRDX: 19.42
Surmodics's Days Payable
increased
from Jun. 2024 (15.96) to Jun. 2025 (26.32).
It may suggest that Surmodicsdelayed paying its suppliers.
Surmodics Days Payable Related Terms
Surmodics Days Payable Historical Data
* Premium members only.
The historical data trend for Surmodics's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Surmodics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surmodics Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Surmodics's Days Payable distribution charts can be found below:
* The bar in red indicates where Surmodics's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Surmodics's Days Payable for the fiscal year that ended in Sep. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surmodics (SRDX) has a Days Payable of 26.32 as of Jun. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Surmodics and its competitors. This is 87% above median its historical median of 14.05. Over the past decade, Surmodics' Days Payable has ranged from 9.42 to 19.42.
Is Surmodics' Days Payable too high?
Surmodics' current Days Payable of 26.32 is 87% above median its 10-year median of 14.05. Over the past 10 years, this metric has ranged from a low of 9.42 to a high of 19.42. The Medical Devices & Instruments industry median Days Payable is 67.87. Surmodics' value of 26.32 is 61.2% below this industry median. Overall, Surmodics has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does Surmodics' Days Payable compare to CBLL and OFIX?
Surmodics' Days Payable of 26.32 can be compared against companies in the Medical Devices & Instruments industry. The industry median Days Payable is 67.87. Surmodics' value of 26.32 is 61.2% below this benchmark. Historically, Surmodics' own Days Payable has ranged from 9.42 to 19.42 over the past decade. While the company's 10-year median is 14.05 vs. the industry median of 67.87, Surmodics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surmodics's current Days Payable of 26.32 is 61.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Surmodics and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surmodics's current Days Payable is 26.32, which is 87% above median its own 10-year median of 14.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surmodics stock overvalued right now?
Surmodics (SRDX) has a current Days Payable of 26.32. The stock's GF Value™ is $32.10, compared to a current price of $42.98 — trading 33.9% above its estimated fair value. The current Days Payable is 26.32, which is 87% above median its 10-year median of 14.05 and 61.2% below the Medical Devices & Instruments industry median of 67.87. Surmodics' overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Surmodics (SRDX), the current Days Payable is 26.32 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Surmodics (SRDX) Overvalued in 2026?
Based on GuruFocus' analysis, Surmodics stock appears to be overvalued.
The current stock price of $42.98 is trading 33.9% above its estimated GF Value™ of $32.10.
Key valuation signals for SRDX:
Days Payable: 26.32 (87% above median its 10-year median of 14.05)
GF Value™: $32.10 vs. price of $42.98 (33.9% above fair value)
Industry Position: 61.2% below the Medical Devices & Instruments median
No single metric tells the full story. See the SRDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.
51GF Score
Get the complete analysis for SRDX
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SRDX has been successfully added to your 
